G. Charpentier

A genome-wide association study identifies novel risk loci for type 2 diabetes

Robert Sladek, Ghislain Rocheleau, Johan Rung et al. · Nature · 2007 · 3K citations

Genome-wide Association Study, Genetic Determinant, Diabetes Epidemiology +10

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott, Laura J. Scott, Reedik Mägi et al. · Diabetes · 2017 · 796 citations · Full text

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

Nabila Bouatia‐Naji, Amélie Bonnefond, Christine Cavalcanti-Proença et al. · Nature Genetics · 2008 · 607 citations · Full text

Metabolic Syndrome, Plasma Glucose Levels, Diabetes Epidemiology +8

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew Ahmann, Matthew Capehorn, G. Charpentier et al. · Diabetes Care · 2017 · 542 citations

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia

Johan Rung, Stéphane Cauchi, Anders Albrechtsen et al. · Nature Genetics · 2009 · 476 citations

Insulin Resistance, Metabolic Syndrome, Genetic Variant +12